Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Firuglipel (DS-8500a) Effects on Beta Cell Function in T2DM
NCT02669732Phase 2Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Jan 2016
- Primary completion
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of firuglipel in type 2 diabetes mellitus (T2DM), sponsored by Daiichi Sankyo Co., Ltd.. Started Jan 2016; status: completed.
02
Drugs
firuglipel
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02669732.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02669732.